Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Transplantation and Cellular Therapy|February 19, 2022
Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy-A Single Center Prospective Cohort StudyRon Ram, Tal Freund, Tami Halperin, et al.
European Journal of Haematology|September 26, 2021
Characteristics and recognition of early infections in patients treated with commercial anti-CD19 CAR-T cellsOfrat Beyar-Katz, Nino Kikozashvili, Yael Bar On, et al.
Leukemia & Lymphoma|April 21, 2021
Post-transplantation maintenance with sorafenib or midostaurin for FLT3 positive AML patients - a multicenter retrospective observational studyShai Shimony, Moshe Yeshurun, Ofir Wolach, et al.
Annals of Hematology|June 22, 2022
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysisOfir Wolach, Avraham Frisch, Liat Shargian, et al.
Annals of Hematology|June 22, 2022
Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells-single-center experienceOfrat Beyar-Katz, Chava Perry, Yael Bar On, et al.
Hematological Oncology|May 27, 2026
Belumosudil in the Management of Heavily Pretreated Prolonged Chronic GVHD: A Retrospective Multicenter Real-World StudyBen Varon, Ron Ram, Avichai Shimoni, et al.
European Journal of Haematology|October 17, 2022
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter studyLiat Shargian, Odelia Amit, Hanna Bernstine, et al.
Respiration; International Review of Thoracic Diseases|June 30, 2025
Respiratory Burden in Hematology-Related Bronchiectasis: Clinical Characteristics and Treatable TraitsOphir Freund, Ori Wand, Yitzhac Hadad, et al.
Haematologica|February 12, 2026
ICANS mitigation in high-risk elderly patients treated with CD28 co-stimulatory anti-CD19 CAR-T cells using a standardization protocol: a pilot studyGil Fridberg, Odelia Amit, Yehonathan Sherf, et al.
Haematologica|July 8, 2021
Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients - a matched control multicenter cohort studyRon Ram, Sigal Grisariu, Liat Shargian-Alon, et al.
Pageof 4